, Volume 4, Issue 2, pp 123–128 | Cite as

Probable sources of plasma cholesterol during phosphatide induced hypercholesterolemia

  • Sanford O. Byers
  • Meyer Friedman


Rats in isotopic steady state with respect to 4-14C-cholesterol were infused intravenously with massive amounts of lecithin and also injected once with Na acetate3H. During the following 8 hr their plasma gained an average of 11.3 mg of cholesterol; the specific activity of14C-cholesterol fell in plasma while total14C-cholesterol and3H activity doubled as compared to controls. The specific activity of14C-cholesterol diminished in livers of rats receiving lecithin but not in controls. Specific activity of either isotope in cholesterol of intestine, lungs, muscle, skin and brains was the same in control and experimental groups. Total activity of14C and3H fell in cholesterol of liver. The results show that plasma accumulation of cholesterol during lecithin infusion derives from both cholesterol pre-existing prior to infusion and from that newly synthesized after the start of infusion and that about one third of this cholesterol of mixed origin is supplied from the liver. The authors speculatively suggest skin as a likely source for most of the remainder, with a small additional contribution from brain.


Cholesterol Lecithin Plasma Cholesterol Lesterol Liver Cholesterol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Byers, S. O., M. Friedman and T. Sugiyama, J. Biol. Chem.237, 3375–3380 (1962).PubMedGoogle Scholar
  2. 2.
    Wilson, J. D., J. Lipid Res.5, 409–417 (1964).PubMedGoogle Scholar
  3. 3.
    Abell, L. L., B. B. Levy, B. B. Brodie and F. E. Kendall, J. Biol. Chem.195, 357–366 (1952).Google Scholar
  4. 4.
    Folch, J., M. Leer and G. H. Sloane Stanley, J. Biol. Chem.226, 497–509 (1957).PubMedGoogle Scholar
  5. 5.
    Saifer, A. and O. F. Kammerer, J. Biol. Chem.,164, 657–677 (1946).Google Scholar
  6. 6.
    Eckles, N. E., C. B. Taylor, D. J. Campbell and R. G. Gould, J. Lab. Clin. Med.,46, 359–371 (1955).PubMedGoogle Scholar
  7. 7.
    Avigan, J., D. Steinberg and M. Berman, J. Lipid Res.3, 216–221 (1962).Google Scholar
  8. 8.
    Sharpe, L. M., G. G. Culbreth and J. R. Klein, Proc. Soc. Exptl. Biol. Med.74, 681–685 (1950).Google Scholar
  9. 9.
    Byers, S. O., and M. Friedman, Proc. Soc. Exper. Biol. Med.92, 459–462 (1956).Google Scholar
  10. 10.
    Chevallier, F., and F. Giraud, Bull. Soc. Chim. Biol.48, 787–801 (1966).PubMedGoogle Scholar
  11. 11.
    Chevallier, F., and L. Petit, Exper. Neurology16, 250–254 (1966).CrossRefGoogle Scholar
  12. 12.
    Kabara, J. J., A. P. Alvares, C. Riegel and J. T. McLaughlin, Proc. Soc. Exptl. Biol. Med.120, 37–41 (1965).Google Scholar
  13. 13.
    Duncan, C. H., M. M. Best and R. J. Lubbe, Metabolism13, 1–7 (1964).PubMedCrossRefGoogle Scholar

Copyright information

© American Oil Chemists’ Society 1969

Authors and Affiliations

  • Sanford O. Byers
    • 1
  • Meyer Friedman
    • 1
  1. 1.Harold Brunn InstituteMount Zion Hospital and Medical CenterSan Francisco

Personalised recommendations